Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 22 |
| Active Pipeline (Recruiting Now) | 14 (10) |
| Completed vs Stopped Early | 1 / 1 (4.5%) |
| Median Closed Actual Enrollment | 118 participants |
| Physical Hospital Site Disclosure | 100.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Top Partner U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Shared Protocols |
|---|---|---|
| Fujian Medical University Union Hospital | Fuzhou, Fujian | 5 |
| Shenzhen Second People's Hospital | Shenzhen, Guangdong | 4 |
| The First Affiliated Hospital of Nanchang University | Nanchang, Jiangxi | 3 |
Explore interactive annual charts and M&A subsidiary rollups in the Eye & ENT Hospital of Fudan University Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.